Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost

Gregory Katz, Clark L. Springs, E. Randy Craven, Michela Montecchi-Palmer

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost'. Together they form a unique fingerprint.

Medicine & Life Sciences